DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Apr 28, 2017 · 9y ago · Accession 0001193125-17-148058
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Apr 28, 2017
- Report date
- Jun 22, 2017
- Document
- d347227ddef14a.htm
- Size
- 1.0 MB